Niki BioSolutions, Inc. (NIKI) vs Psyence Biomedical Ltd. (PBM)
Over the past year, NIKI lagged PBM — -97.86% vs -73.54% annualized total return (price plus dividends).
A side-by-side comparison of Niki BioSolutions, Inc. and Psyence Biomedical Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
Total return — NIKI vs PBM
growth of $100 · dividends reinvested · last 3yMetrics side by side
Did NIKI beat PBM?
Over the past year, NIKI lagged PBM — -97.86% vs -73.54% annualized total return (price plus dividends).
Total return (annualized)
| Metric | NIKI | PBM |
|---|---|---|
| Total return (1Y) | -97.86% | -73.54% |
| Total return CAGR (3Y) | -71.83% | N/A |
| Total return CAGR (5Y) | -71.40% | N/A |
PBM is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Frequently asked
- Has NIKI beaten PBM?
- Over the past year, NIKI lagged PBM — -97.86% vs -73.54% annualized total return (price plus dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.